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The chemotherapeutic investigations which have been in progress 
in these laboratories for several years have yielded a number of sub- 
stances  of striking activity in  the treatment of experimental infec- 
tions such as thos  e produced in laboratory animals by various species 
of trypanosomes, the spirochetes of relapsing fever, and Treponema 
pallidum.  Among the  first  of  these  substances  was  the  amide  of 
N-phenylglycine-p-arsonic acid,  a  description of which is  given by 
Dr.  Jacobs  and  Dr.  Heidelberger,  in  the  chemical series  of  these 
papers?  It may be said that while N-phenylglycine-p-arsonic acid, 
described  in  German  Patent,  No.  204,664, is a  substance of prac- 
tically  no  importance in  the  treatment of these infections, arseno- 
phenylglycine, produced from it by reduction, was among the earliest 
of  the  highly  active  trypanocidal  agents.  The amide of  this acid 
which has the structural formula 
OH 
NHCH2CONH~ 
was first made and studied in the fall of 1915 with results which at 
once opened the way to the development of  a  number of important 
substances which will be dealt with in subsequent papers. 
I Jacobs, W. A., and Heidelberger,  M., J. Exp. Med., 1919, xxx, 411. 
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Methods of Employing N-Phenflglycineamide-p-Arsonic  Acid. 
The  amide of  N-phenylglycine-p-arsonic acid,  or  A  63  as it was 
designated  on  our  lists, presents no difficulty in the way of its use 
for purposes  of  animal  experimentation.  In the form of the mono- 
sodium salt,  the drug is readily soluble in water  in  concentrations 
as  high  as  50  per  cent and when injected directly into the tissues 
or  into  the  body  cavities  of  animals,  it  is  readily absorbed and 
produces but slight irritation or local injury. 
Preparation  of Solutions.--Solutions  of A  63  may be prepared by 
dissolving the monosodium salt in sterile distilled water, or in case 
the acid is used, the requisite amount of sodium hydroxide (0.37  cc. 
of N sodium hydroxide per 0.100  gin.  of drug)  to  form the mono- 
sodium salt should be added slowly with stirring.  The product then 
dissolves without difficulty. 
Administration.--This  drug  may be  administered  to  animals  by 
almost any route which is convenient and has been used subcutane- 
ously,  intramuscularly, intraperitoneally,  intravenously,  and  per  os 
with  no  especial  disadvantage  following its  use by any  except the 
last named route. 
Measurement  of Doses.JThe  measurement of  doses  was  accom- 
plished  in  one  of  three  ways.  With  the  smaller  animals,  a  stock 
solution  of  the  drug  was  prepared  from  which  individual  doses 
for mice were measured by the use of a  Fornier tuberculin syringe 
graduated in hundredths of a  cubic centimeter; in the case of rats 
and  guinea pigs,  doses  were measured with  standardized  pipettes. 
Finally, doses for larger animals such as rabbits  and monkeys were 
always weighed and prepared  separately.  The  values  given in  all 
cases refer to amounts of the monosodium salt which was used almost 
exclusively.  These  figures  may be  transposed  into  equivalents  of 
the acid by the use of the factor 0.9 if desired. 
Minimum Lethal Dose. 
Although A  63  contains 24.57  per cent of arsenic, its toxicity for 
laboratory  animals  is  comparatively low.  The  lethal  dose  of  the 
drug varies between the extremes of 0.75  and 2.75  gin. per kilo  of 
body weight for the  different animal species in  which it  has  been 
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Mice.wThe  tolerance of mice is particularly  good, as is indicated 
by the figures given in Table I  which represents the combined results 
of several experiments carried out with mice.  From the data at our 
disposal, we would place the minimum lethal dose for mice at 2.5 to 
2.75 gm. per kilo of mouse when given subcutaneously, 2 to 2.25 gin. 
given intraperitoneally,  and 2 gin. when given intravenously.  These 
figures show a  reasonably close agreement in the toxicity of the drug 
when  administered  by these  routes,  and  the  results  obtained  from 
-successive  experiments  were  comparatively  uniform.  Some  mice 
survive even higher  doses than  those shown in  the  table,  and  con- 
versely an occasional mouse may succumb to lower doses than  those 
given  as  the  lethal  or minimum  lethal  dose;  but  we  have  had  no 
TABLE  I. 
Lalsal Effects Obtained  from tke A dministratien of a 5 Per Cent Solution of N-Phenyl- 
glydneamide-p-Arsonic  Add to Mice Sn Doses Equivalent  to 1.75 to 
2.5 Gin. per Kilo of Mouse. 
Dose per kilo. 
~m. 
2.5 
2.25 
2.0 
1.75 
Subcutaneous  injection. 
No. of mice 
used.  No. died. 
0 
0 
0 
0 
Intraperitoneal  injection. 
No. of mice  No. died. 
used. 
5  1 
21  5 
• 25  2 
8.  0 
Intravenous iniection. 
No. of mice  No. died. 
used. 
2  2 
4  1 
4  1 
4  0 
deaths  resulting  from  doses  of  the  drug  below  2  gm.  per  kilo  of 
mouse. 
Rats.--The  resistance  of  white  rats  to  the  toxic  action  is  lower 
and  more  irregular  than  that  of  any  other  animal  with  which  we 
have  worked.  When  the  drug  is  administered  intraperitoneally, 
doses as small as 0.75 gin. per kilo are sufficient to cause death in a 
fair percentage of ariimals and yet some rats will survive as much as 
1.75  gin. per kilo.  The results obtained from subcutaneous adminis- 
tration  are distinctly better;  the minimum  lethal dose rises to 1 gin. 
per kilo  and  the  action  of  the  drug  is  definitely more  constant,  as 
may be seen by an examination  of the results from the  two experi- 
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TABLE  II. 
Lethal  Effects  Obtained from  the Subcutaneous  Administration  of a  10  Per Cent 
Solution  of N-Phenflglycineamide-p-Arsonic  Acid to Rats and from the 
Intraperitoneal  Administration of a 3 Per Cent Solution. 
Subcutaneous injection.  Intraperitoneal injection. 
Dose per kilo. 
No. of rats used.  No. died.  No. of rats used.  No. died. 
gm. 
1.50 
1.25 
1.00 
0.90 
0.75 
0.60 
0.50 
5 
5 
9 
5 
5 
5 
5 
Guinea  Pigs.--Contrary  to the opinion which is generally held  as 
to the tolerance of guinea pigs for arsenicals, these animals withstand 
relatively large doses of A 63 and the resistance of individual animals 
appears  to be fairly uniform.  The  lethal  dose found for  the  drug 
was 1.5 gm. per kilo of body weight whether given subcutaneously or 
intraperitoneally  (Table III). 
TABLE HI. 
Lethal Effects Obtained from the Administration of a 20 Per Cent Solution  of 
N-Phenylglydneamide-p-Arsonic  Acid to Guinea Pigs. 
Subcutaneous injection.  Intraperitoneal injection. 
Dose per kilo. 
No. of guinea pigs  No. of guinea pigs  used,  No. died.  used.  No. died. 
gm. 
1.75 
1.50 
1.40 
1.25 
Rabbits.--A great deal of time has been devoted to the study of the 
toxic  action  of A  63  in  rabbits,  The  major part  of this  work was 
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of subcutaneous, intramuscular, and per os administrations have all 
been investigated to some extent.  The solutions used in the experi- 
ments varied between concentrations of 5  and  50  per cent,  partly 
for the purpose of studying the effects of the use of different volume 
doses and partly for the purpose of determining the influence of such 
factors as rate of administration and concentration of solutions upon 
the action of the drug. 
It was found that as much as 20 cc. per kilo of a  5 to 10 per cent 
solution could be injected intravenously into rabbits about as rapidly 
as one wished, and that in general, solutions of low concentration (5 to 
10 per cent) were better borne than those of a higher concentration. 
The  effects of concentration were less  evident, however, when the 
drug was administered by other routes, and more concentrated solu- 
tions  were  employed as  a  means  of  reducing the  volume  of  fluid 
which had to be used. 
Under the conditions described, the minimum lethal dose for rab- 
bits was found to be 0.75  to 0.9  gin. per kilo of body weight when 
given  intravenously  and  1.1  gin.  given  either  subcutaneously  or 
intramuscularly, with lethal effects as indicated by the experiments 
recorded in Table IV. 
TABLE  IV. 
Lethal Effects Obtained from the Intravenous  Administration of a 5 to 10 Per Cent 
Solution  of N-Pkenylglycineamide-p-Arsonic  Acid to Rabbits  and from the 
Subcutaneous or Intramuscular Administration of 50 
Per Cent Solutions. 
Dose per kilo. 
gm. 
1.25 
1.1 
1.0 
0.9 
0.75 
Subcutaneous injection. 
No. of rabbits 
used.  No. died. 
Intramuscular  injection. 
[go. of rabbit~  No. died. 
used. 
4  3 
4  2 
3  0 
Intravenous injection. 
No. of rabbits  used.  No. died. 
6  3 
12  4 
I0  I 
Our  experience in  giving this  drug to  rabbits  by mouth may be 
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a stomach tube following the administration of a small dose of bicar- 
bonate of soda.  In all, there were only seven rabbits which received 
the drug in this way.  Two of them were given doses of 1.25 gm. 
per kilo of body weight, four were given 1  gm., and one was given 
0.75 gm.  The last of these animals showed no ill effects from the 
drug and only two of the others actually succumbed to its  action, 
both of which received a dose of 1 gm. per kilo.  One of these rabbits 
lived 4  days and the other 24 days after the administration of the 
drug.  It appeared certain, however, that none of the other animals 
would recover completely and they were killed at different times for 
purposes of pathological examination.  As the matter stands, there- 
fore, we are hardly justified in attempting to fix the toxic limits of 
A 63 when given per os. 
Monkeys.--Lastly, we have used two monkeys (Macacus rhesus) in 
studying the toxic action of A 63.  The first monkey, a female weigh- 
/ng 2,325 gm., was given an initial dose of 0.75 gm. per kilo of body 
weight,  The animal was observed for 5 days during which time no 
ill effect from the drug could be detected, and a  second dose of 1 
gm. per kilo was given with a like result.  4 days later, the animal 
received its third dose which was 1.25 gm. per kilo.  FoUowing this 
dose,  the only evidence of intoxication noted was possibly a  slight 
loss of weight (75  gm.).  At the end of 3 weeks, the  weight of the 
animal was 2,450 gm.,  and a  fourth dose of the drug was given-- 
this time 1.5  gin. per kilo, or double the initial dose.  The monkey 
showed slight signs of intoxication lasting for a few days, followed by 
rapid recovery.  The animal was kept under observation for 3 months 
and was then killed for pathological purposes. 
The second monkey used was  likewise  a  female rhesus weighing 
2,650 gin.  This monkey was given an initial dose of 1.25 g~. per 
kilo  intravenously.  There  was  a  loss  of  weight  in  this  animal 
amounting to 175 gm., but no other evidence of intoxication developed, 
and  after waiting  1 week,  a  second dose of  1.5  gm.  per  kilo  was 
given; death followed within 24 hours. 
These two  experiments are  cited merely to  show  that  monkeys 
possess  a degree of tolerance for A 63 comparable with that of other 
animals and that they react to the drug in much the same way. WADE  H.  BROWN  AND LOUISE  PEARCE  423 
Represented  graphically,  the-values  obtained  for  the  minimum 
lethal dose of this  drug in the five species of animals  studied would 
form  a  curve such as that  given in Text-fig.  1.  While these values 
are not strictly comparable on account of differences in the mode of 
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TExT-FIG. 1. Comparative magnitudes of the minimum lethal dose of N-phenyl- 
giycineamide-p-arsonic acid  for  different  animal  species.  The  dose given for 
monkeys is an approximate estimate. 
administration  used,  they will serve to indicate  the  relative  magni- 
tude of the toxic dose for different animal species.  The mean toxic 
dose  for  this  group  of  animals  is  found  to  be  approximately  1.28 
gm.  per kilo;  the maximum  variation  from  this  mean  is  as  1:1.75 
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Symptoms and Course of the Intoxication. 
The symptom-complex of the intoxication produced by N-phenyl- 
glycineamide-p-arsonic acid in laboratory animals is characterized by 
two groups of phenomena, one nervous and the other nutritional in 
character.  The most prominent of  these symptoms appear  at  an 
early period of the intoxication, as pronounced tremors with  inco- 
ordination of movements, or in extreme cases, as clonic spasm, usually 
associated with some weakness or complete prostration.  With remis- 
sion of these early symptoms in mice, a tic develops which is charac- 
terized by peculiar jerky movements of the head and occasionally 
by the continuous circling movements of dancing mice.  Nutritional 
disturbances are indicated chiefly by a loss of appetite, more or less 
weakness, loss of weight, and occasionally by diarrhea.  Altogether 
the  picture is  one previously recognized and  described as  charac- 
teristic of the toxic action of  a  number of pentavalent arsenicals, 
particularly of arsacetin,  dichlorophenolarsonic acid,  and  aminohy- 
droxyphenylarsonic acid. 
These symptoms are by no means constant either as to the fre- 
quency or the intensity of their occurrence in different animal species 
or in individual animals of the same species. 
Miee.--In  mice  symptoms  of  intoxication  occur  only  following 
relatively large doses of the drug (1.75 gin. per kilo and above) and 
even  then  are  not  of  constant  occurrence.  In  the  most  marked 
cases,  mice show violent muscular tremors on being disturbed and 
marked locomotor incoordination.  After 2 or 3 days, these symptoms 
disappear entirely or gradually give place to the tic described, which 
in turn rarely persists for more than a  week.  Disturbances of this 
general character appear  to  be  more pronounced following subcu- 
taneous  and  intravenous  administrations  of  the  drug than  after 
intraperitoneal administration. 
Mice also show some nutritional disturbances for 2 or 3 days fol- 
lowing  toxic doses of the drug but make a rapid recovery with  an 
increase in weight above their normal level and remain subsequently 
in excellent condition. 
Rats.--Rats are, on the whole, the most sensitive animals to this 
drug and individual idiosyncrasy is  quite pronounced among them. WADE  H. BROWN  AND LOUISE PEARCE  425 
Nevertheless, toxic symptoms in  these animals  are fairly well con- 
fined to  doses  within what we  regard as  the  lethal  range.  While 
some rats show no toxic symptoms at  all,  in others,  tremors, inco- 
ordination,  convulsions,  weakness,  and  emaciation  reach  a  most 
extreme grade and progress to a  lethal termination, recovery under 
such conditions being very rare. 
Guinea Pigs.--Guinea pigs on the other hand are quite resistant to 
A  63.  They show very slight  evidence of intoxication either of a 
nervous  or  of  a  nutritional  character from doses  below  the  lethal 
level.  The  dose  that  is  survived  is  usually  well  borne  and  even 
lethal  doses  produce  comparatively  slight  tremors,  unsteadiness, 
weakness, or loss of weight. 
Rabbits.--The  reaction of rabbits to A  63 is rather irregular.  By 
whatever route the drug is administered, doses above 0.5 to 0.6 gm. 
per kilo of body weight cause some loss of appetite with an initial 
loss of weight which is in proportion  to  the size  of the dose used. 
With  doses of 0.75  to 0.9  gm. per kilo of body weight, the loss of 
weight in surviving animals may reach as much as 200  to 300  gm. 
and is associated with some degree of weakness.  This loss of weight, 
however, is  quickly regained,  leaving no  symptomatic evidence of 
intoxication.  Nervous  phenomena  of  the  exact  type  described  in 
mice  and  rats  do  not  occur in  rabbits.  Instead,  rabbits  manifest 
some hypersensitiveness in the milder cases of intoxication, while in 
extreme  cases  incoordination  develops  with  a  tendency  to  clonic 
spasms, and there is eventual loss of muscular control or even paraly- 
sis.  As  in the case of the rat, pronounced nervous symptoms in rab- 
bits nearly always portend a  lethal outcome so that these phenomena 
cannot be said to occur as symptoms of a sublethal intoxication. 
When toxic doses  are given to  rabbits  per os,  the drug produces 
symptoms which are not observed when it is given by other routes, 
the characteristic feature of which is a marked abdominal distention 
with flatulence as a result of atony of the colon.  Associated with this 
condition,  there is  a  loss  of  appetite,  diarrhea,  progressive loss  of 
weight,  and  weakness.  The  condition is  extremely persistent  and 
recovery, if it occurs at all, is problematical. 
Monkeys.--In  our limited experience with monkeys, we have ob- 
served no symptoms of intoxication other than slight loss of weight 
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Having described the symptoms of intoxication produced by A 63, 
we shall now take up the question of the time element in these toxic 
reactions.  In mice symptoms of intoxication are usually apparent 
within 24 hours after the administration of the drug but may be de- 
layed until the 2nd day.  Death also occurs relatively early in these 
animals and is rare after 48 to 72 hours.  Symptomatic recovery is 
relatively prompt. 
Rats, on the other hand, usually show no symptoms of intoxication 
until the 2nd or 3rd day except with very large doses of the drug. 
Out  of twenty-eight rats  that died as  a  result of intoxication with 
doses  below  1.5  gm.  per  kilo  of  body  weight,  the  e~rliest  death 
occurred 3 days after the administration of the drug, the latest deaths 
10, 11, and 14 days, while the average period was 6 days.  Recovery 
in rats is also a slow and uncertain process. 
Symptoms of intoxication in guinea pigs usually make their appear- 
ance on the 2nd day following the administration of the drug.  Among 
the deaths recorded in our series from doses below 2  gin. per kilo, 
the earliest occurred 2 days and the latest 7 days after the administra- 
tion of the drug with an average period of 4 days survival.  Recovery 
in guinea pigs is usually prompt and complete. 
Of the rabbits which died after intravenous injections of a  single 
dose of A  63,  one with the smallest dose (0.75  gm.) died in almost 
exactly 24 hours, while the longest survival was 6 days and the aver- 
age 2.6  days.  The minor symptoms of intoxication in rabbits  are 
not apparent as a rule until the 2nd day, while the graver symptoms 
occur more promptly.  As previously indicated, symptomatic recovery 
in the rabbit is usually prompt and complete. 
Pathology of the Intoxication. 
The  pathological  changes  produced  in  the  animal  organism  by 
toxic doses of A  63  constitute an important phase of its toxicologic 
action.  Viewed from the standpoint of the bearing of these changes 
upon the possible usefulness of the drug as a therapeutic agent, this 
phase  of the  subject  resolves itself  largely into  a  consideration of 
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Local Effects. 
As  we have  already indicated,  the injury produced by the  drug 
at the site of injection is almost negligible.  Full toxic doses may be 
injected into  the veins of animals  even in  saturated solution,  with 
practically no  local reaction.  When a  50  per  cent solution  of the 
drug is  injected into  the  subcutaneous  tissues  of animals,  a  slight 
edema develops  at  the  site  of the  injection  but  clears  up  almost 
immediately, leaving such slight evidences of tissue reaction as are 
barely recognized from external examination.  If given intramuscu- 
larly in  amounts small enough to  obviate mechanical laceration of 
the tissues, the reaction which follows is likewise very mild and is of 
essentially the  same  character as  that  which  follows  subcutaneous 
administration. 
Systemic Effects. 
The effects produced by the drug upon  the organism as  a  whole 
are of much more importance than those of a purely local character. 
These effects are divisible into major and minor phases of pathologi- 
cal action, the details of which differ somewhat in  different animal 
species as well as with the amount of the drug used and the route of 
administration  employed.  In  general,  however,  the  changes  seen 
during the early stages of the intoxication consist in moderate vascu- 
lar dilatation and congestion with a  few scattered petechial hemor- 
rhages, occasional effusions into the serous cavities, and widespread 
cellular degenerations or even necrosis in some organs.  The organs 
which share most prominently in these changes are the kidneys and 
adrenals, and the cardiovascular system, with an uncertain involve- 
ment of the  central nervous system,  the gastrointestinal  tract,  the 
blood,  and  blood-formative organs;  the  changes produced in  other 
organs  appear  to  be  of minor importance.  Animals which survive 
the intoxication rarely show lesions in organs other than the kidneys 
and myocardium. 
Kidneys.--The  central  feature  of  the  pathological  action  in  all 
animals is the injury to the kidneys.  In acute poisoning, the kidneys 
are somewhat enlarged and tend to be pale except for the presence of 
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which may extend outward along the medullary rays to the capsular 
surface.  The  glomerular tufts  are  usually  swollen,  the  capillaries 
congested, and the covering epithelium is  degenerated.  Degenera- 
tion ,or even necrosis of the tubular epithelium is rather widespread 
but occurs chiefly in the ascending loops of Henle and the convoluted 
tubules, particularly those located along the medullary rays and the 
outer portion of the cortex.  The interstitial elements of the kidney 
are, as a rule, much less affected except when overwhelming doses of 
the drug are given. 
As serious as these injuries appear to be in the acute stages, recovery 
is remarkably satisfactory in most animals.  Reaction of the tissue 
elements sets  in  promptly and  restoration of  the injured parts  is 
accomplished within a  short period of time and with comparatively 
slight  scarring  or  distortion  of  the  architecture  except where  the 
initial  destruction  was  unusually  extensive.  In  these  cases,  the 
marks of injury are found in a  growth of connective tissue and in 
round  celled infiltrations  extending along  the  medullary rays  and 
through the outer portion of the cortex, while a few glomeruli show 
shrunken tufts and thickened capsules, all of which gives a granular 
surface to the kidneys. 
Adrenals.--Evidences  of injury to the adrenals consist in swelling, 
with some congestion of the cortical vessels and the occasional pres- 
ence of focal hemorrhages in the cortex.  In guinea pigs, the later 
changes are manifested by  a  decrease in  the  cortical pigmentation 
with well marked degenerative changes in  the  cortex and medulla 
or  even  necroses  in  the  midcortical  zone.  Here  again  recovery 
appears to take place fairly promptly. 
Cardiovascular System.--The  most  pronounced  effects  of  A  63 
upon the cardiovascular system appear during the early stages of the 
intoxication.  There is  a  moderate vascular  dilatation  and  conges- 
tion  throughout the  body  and  a  few  petechial  hemorrhages may 
occur in any of the organs.  The sites of chief importance are the 
kidneys, the adrenals, and heart in which occasional foci of hemor- 
rhage  are  found beneath  the  epicardium and  the  endocardium as 
well as in the myocardium itself.  In several instances, hemorrhages 
from the meningeal vessels have been observed, either in the region 
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Animals which survive the acute poisoning show little evidence of 
either  congestion or  hemorrhage,  but  in  their  stead  one finds  an 
accumulation of more or less fluid in the serous  cavities, perirenal 
edema, and in rare instances an increased tension of the cerebrospinal 
fluid.  These conditions we regard as at least indicative of vascular 
injury.  In  addition  to  such  changes  as  these,  the  myocardium 
shows a moderate fatty degeneration with occasional areas of fibrosis. 
On the whole, the pathological effects of A 63 upon the cardiovascular 
system are not pronounced and the conspicuous congestion, hemor- 
rhage, and degeneration so often observed with arsenicals are largely 
absent from the changes which characterize the action of this drug. 
Central Nervous System.--From the symptoms of the toxic action of 
A 63, one might expect the central nervous system to share the posi- 
tion of chief pathological importance with the kidneys and cardio- 
vascular system.  Such changes as occur, however, are rather obscure 
and  difficult  of  determination  in  laboratory  animals.  We  have 
already  mentioned the  occurrence of  congestion of  the  meningeal 
vessels and occasional hemorrhages together with an increased ten- 
sion of the cerebrospinal fluid.  Histologically, the chief evidences of 
injury are associated with the choroid plexus and with the small and 
medium vessels of the meninges and brain.  The plexus itself shows 
definite degeneration in  some animals and  the tissues immediately 
surrounding the vessels are somewhat edematous.  Apart from these 
changes,  however,  we  have  been  able  to  demonstrate only minor 
degrees of cellular degeneration of a  rather indefinite character and 
of uncertain extent. 
Blood and  Blood-Formative Organs.--While  the  action  of  A  63 
upon  the  blood  and  blood-formative  organs  forms  an  important 
feature of the effect of the drug, this action is perhaps more physio- 
logical than pathological and hence there is little that can be said in 
the present connection. 
Poisoning with  the  drug  produces  an  initial  destruction  of  red 
blood cells and an accumulation of blood pigments in the spleen, liver, 
and  bone marrow.  The  formative centers,  especially those of  the 
spleen, show degeneration or even necrosis after the administration of 
very large doses of the drug, but following these changes, there is an 
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This is most strikingly shown by a myeloid metaplasia in the spleen 
of rats and mice which is characterized by the presence of large num- 
bers of megacaryocytes.  These changes alone, however, might mean 
very little, since such reactions are easily excited in mice and rats. 
The effect of A 63 upon other organs of the body is relatively incon- 
siderable.  In the liver, parenchymatous and fatty degeneration are 
usually but not constantly present, and in exceptional instances iso- 
lated cells or groups of cells here and there show necrosis.  As a rule, 
these changes clear up very quickly leaving nothing to indicate the 
existence of any previous injury. 
Lesions of the gastrointestinal tract are likewise inconstant and of 
uncertain significance.  During the early stages of the intoxication, a 
catarrhal  condition of the entire tract is not infrequently observed 
but is rarely of serious degree.  An exception to this rule is found in 
animals which have been given the drug by mouth.  These animals 
always show a pronounced and persistent colitis with a lesser degree of 
involvement of the stomach and small intestine.  This, however, is 
clearly referable to the mode of administration of the drug. 
Apart from a knowledge of the character of the lesions which may 
be induced by this drug, the features of chief interest from the patho- 
logical point of view are the promptness with which repair is accom- 
plished and the fact that, as the dose of the drug used falls below the 
level of  the lethal dose,  the extent of  the resulting injury rapidly 
diminishes until,  with  doses  only  slightly  below  the  level  of  the 
lethal dose, organic injury is barely demonstrable.  These features of 
the pathological action of A 63 are both unusual and of considerable 
practical importance in their bearing upon the use of the drug for 
therapeutic purposes. 
Tolerance of Repeated Doses. 
The facts presented thus far have dealt entirely with effects pro- 
duced by the administration of single doses of the drug, which brings 
us to a consideration of the reaction of the animal organism to the use 
of repeated large doses.  This phase of drug action is bound up to a 
large  extent with  two  conditions, first,  the  time during which the 
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toxic  effect,  and  second,  the  character  and  duration  of  the  effect 
produced, whether functional or organic. 
In attempting to arrive at some idea of the time during which A 63 
remained biologically active after being administered to animals, we 
made use of two types of experiments--one based upon protection 
against  infection  and  the  other  upon  superposition  of  fractional 
parts of toxic doses.  In general, it was found by experiments of the 
first class, that the protection afforded such animals as mice against 
infection with Trypanosoma  brucei was practically nil 24 hours after 
the administration of as much as twice the dose of the drug which 
was capable of curing a  24 hour infection of the same organism (0.5 
gm. per kilo).  With rats and with rabbits on the other hand, some 
degree of  protection  still  existed  at  the  end of 48  hours.  In  the 
case of the rabbit, four animals which were inoculated with Trypano- 
soma brucei, 48 hours after having received an intravenous injection 
of 0.5  gin.  of A  63 per kilo, gave the following results: One rabbit 
showed no  protection,  two  were permanently  protected,  and  the 
fourth showed an incubation period of 21 days as contrasted with an 
incubation period of 9 days in controls which received the same dose 
of organisms at the same time. 
From these experiments it appeared that retention of the drug in a 
biologically active  form was  a  variable  condition both  specifically 
and individually, but that in animals such as the rat and the rabbit, 
there was the possibility of the drug's remaining in the body for 48 
hours or even longer in a  condition in which it might still be cap- 
able of exerting toxic effects.  To test this further, we carried out a 
few  experiments on  the  effects of the  administration  of fractional 
parts  of a  toxic dose at  various intervals  of time.  Without  going 
into the details of these experiments, we may say that it was found 
that when the toxic dose of A  63 for rabbits  (0.75  gin. per kilo) was 
divided into three equal parts administered at intervals of 24 hours, 
the toxic effect approached that produced by the administration of 
the entire amount of drug at  one time.  This,  of course, might be 
interpreted either as evidence of an accumulation of drug or as evi- 
dence of superposition  of  effects  notwithstanding  the fact that no 
toxic effect could be recognized from the administration of a  single 
such fractional part of the toxic dose. 432  TRYPANOSOME AND  SPIROCHETE INFECTIONS 
Combining these facts with what we had already learned in regard 
to the general reaction of animals to single doses of A 63, we under- 
took some experiments intended to determine the tolerance of mice 
and of rabbits to prolonged repetition of large doses of the drug and 
something of the interval at which such repetitions might be carried 
out successfully.  The results obtained with one series  of mice are 
summarized in Table V. 
These mice were given an initial dose of 2 gm. of A 63 per kilo of 
body weight injected into the peritoneal cavity.  The injections were 
repeated at weekly intervals and the dose was progressively increased 
up to 3 gm. per kilo.  The sixth and last dose of 2.5 gin. per kilo was 
TABLE V. 
Tolerance of Mice to Intraperitoneal Administrations  of Increasing Doses of 
N-Pkenylglydneamide-p-Arsonic  Add Given at Weekly Intervals. 
No. of injection.  Dose per kilo.  No. of mice used.  No. intoxicated.  No. died. 
1 
2 
3 
4 
5 
6t 
gmo 
2.00 
2.25 
2.50 
2.75 
3.00 
2.50 (i.v.) 
15 
13 
13 
11 
11 
9 
2 
0 
2* 
0 
0 
3 
* These two mice were toxic after the first dose. 
t The last injection was given intravenously. 
then  given intravenously.  Five  of  the  fifteen mice showed symp- 
toms of intoxication following the administration of the first dose and 
two  of these died.  Two others  died after receiving the third dose 
(2.5 gm.) but the remaining eleven mice survived the administration 
of 3 gin. per kilo with no evidence of intoxication, indicating a definite 
increase in their tolerance to intraperitoneal administrations of the 
drug.  When  the  route  of  administration was  changed,  these  ani- 
mals still showed a  resistance to the drug slightly greater than that 
of normal mice. 
Experiments of a  similar character were carried out with rabbits. 
In this case, three routes of administration were used--subcutaneous, 
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what  was  regarded  as  comparable  levels  for  the  various  routes  of 
administration;  i.e.,  0.75  gm.  per kilo intravenously  and  1  gin.  per 
kilo given either subcutaneously or intramuscularly.  Animals of the 
subcutaneous  and  intramuscular  series  received  their  last  dose  in- 
travenously and those of the intravenous series were divided into two 
TABLE VI. 
Tolerance of Rabbits  to Increasing  Doses of N-Pkenylglycineamide-p-Arsonic  Acid 
Given at Weekly Intervals,  (A) Subcutaneously,  (B) Intramuscularly, 
and (C) Intravenously. 
No. of injection.  Dose per kilo.  No. of rabbits used.  No. intoxicated.  No. died. 
A  1 
2 
3 
4 
5 
6* 
B  1 
2 
3 
4 
5 
6* 
c  1 
2 
3 
4 
5 
6* 
gm° 
1.00 
1.00 
1.10 
1.25 
1.3s 
1.1o 
1.00 
1.00 
1.10 
1.25 
1.35 
1.10 
0.75 
0.75 
0.90 
1.00 
1.10 
1.35 
10 
9 
9 
9 
8 
8 
0 
0 
0 
0 
0 
0 
* The last injections of Series A and B were given intravenously; in Series C, 
four rabbits were injected subcutaneously and four intramuscularly. 
groups one of which was given the last dose subcutaneously and the 
other  intramuscularly.  The  results  of  these  experiments  are  given 
in Table VI. 
Following the first dose,  one rabbit of the intravenous series was 
extremely  toxic  and  died  within  24  hours.  A  second  rabbit  was 
slightly  toxic  but  all  the  others  remained  in  good  condition.  No 434  TRYPANOSOME  AND  SPIROCHETE  INFECTIONS 
other  toxic  manifestations  developed  until  the  fourth  dose  of  the 
series was given, when one rabbit of the nine which received the dose 
of 1 gin. per kilo intravenously became toxic and died  after  17 days. 
The  fourteen  remaining  rabbits  were  carried  through  to  the  con- 
clusion of the experiment with no symptoms suggestive of a harmful 
effect other than slight fluctuations in weight. 
The dose in the intravenous series was raised progressively from 0.75 
gin.  per kilo  of  body weight to 1.1  gin.,  which  in our  experience is 
almost uniformly fatal when given to normal rabbits, with the loss of 
only two out of the ten rabbits; the eight rabbits which received the 
dose of 1.1 gin. survived with no evidence whatsoever of intoxication. 
These eight rabbits were then given a  dose of 1.35  gin.  of A  63 per 
kilo  of body weight either  subcutaneously or  intramuscularly  with 
one death  following an intramuscular  injection.  The  other  rabbits 
remained  entirely  normal  and  continued  to gain weight.  With  the 
subcutaneous  and  intramuscular  series,  the  dose was raised  from  1 
gm. per kilo of body weight to 1.35 gin. with no  toxic developments, 
and all these animals were then given 1.1 gm. of the drug by the intra- 
venous route.  In  this  case,  the weights declined slightly but there 
was no  other  sign  of intoxication.  It is  to be noted  that  all  three 
groups  of rabbits  were carried  to  a  point where  they not only sur- 
vived  doses  which  are  ordinarily  fatal  but  that  when  a  normally 
lethal dose was given by a  route other than that  to which they had 
been accustomed, only one of the fourteen rabbits succumbed, while 
the others showed little or no ill effects. 
At the  conclusion  of this  experiment,  the  entire  group  of rabbits 
was killed for pathological examination.  On opening these animals, 
there  was  a  strong  odor  of  garlic--a  condition  never  noted  in  an 
animal which had died from a single dose of the drug.  Pathologically, 
the only changes found were small subcutaneous abscesses or abscesses 
in the lumbar muscles of animals which had received repeated injec- 
tions in the same regions, a  slight fatty degeneration of the myocar- 
dium  with  a  few patches  of  fibrosis,  and  chronic  nephritis.  The 
injuries  to  the  heart  muscle and  to  the kidneys were definitely more 
pronounced  in  the  rabbits  of  the  intravenous  group  than  in the 
others.  With reference to the kidneys of this group, we would classify 
them as two with slight lesions, two with moderate lesions, and four 
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The total amount of drug received by each of these rabbits during 
a period of 36 days was 5.85 gin. per kilo in one group and 6.8 gin. per 
kilo in the other, or 1.437  to 1.67 gin. of arsenic administered within 
a period of 5 weeks.  Finally, it should be recalled that the toxic dose 
of A  63  for rabbits  is  lower  than  that  for  any other animal with 
which we have worked except the rat, and that the mice previously 
referred to received more than twice these amounts of the drug. 
Our limited experience with monkeys, as previously stated, merely 
served to indicate that under properly chosen conditions,  they too 
would respond to repeated doses in essentially the same way as rab- 
bits or mice.  While we do not know what the lethal dose of this drug 
is for monkeys, it is probably not less than 1 to 1.25 gin. per kilo of 
body weight, or approximately the same as that for guinea pigs  and 
considerably more than that for the rabbit.  In the one instance in 
which gradually increasing doses of A 63 were given to a monkey, we 
succeeded in giving as much as 1.5 gin. per kilo as the final dose with 
very slight  intoxication  resulting.  When  this  animal  was  killed  3 
months  later  for  pathological  examination,  the  organs  appeared 
normal. 
CONCLUSION. 
The essential facts to be gathered from these studies of the toxico- 
logic  action  of  N-phenylglycineamide-p-arsonic acid  may be  sum- 
marized very briefly.  The substance is one which lends itself well to 
almost any method of administration and can be given to animals in 
very large doses.  The  tolerance of different animal species varies 
rather widely but with one exception the reaction of laboratory ani- 
mals to toxic doses of the drug is  of favorable character.  That is, 
toxic effects are confined to  doses  relatively close to  the minimum 
lethal dose and the recovery of animals from sublethal intoxications 
is remarkably rapid and complete.  This feature of the action of the 
drug makes possible the repeated administration of even very large 
doses at comparatively short intervals of time without incurring the 
dangers incident to cumulative action or to superposition of toxic effects. 
On the contrary, by taking advantage of this peculiarity of action, 
it  is  possible  to  develop such  a  degree of tolerance on the part  of 
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increased to  a  point well above that which is  fatal to  the normal 
animal, and this stands out as the feature of the toxicologic  action of 
N-phenylglycineamide-p-arsonic  acid which is of greatest significance 
in the use of the drug for therapeutic purposes. 